Celebrating our 10th anniversary – Unlock our special offer today

US FDA chief Califf places ‘stressed’ and ‘challenged’ CTP under external review

US Food and Drug Administration (FDA) commissioner Robert Califf has authorised an external review of the Center for Tobacco Products (CTP), citing a “series of challenges that have tested our regulatory frameworks and stressed the agency’s operations”.

Califf said the CTP faced significant challenges in navigating the complex policy issues as well as determining enforcement activities brought about by the increasing number of novel tobacco products on the market. The CTP will continue to review pending applications and take enforcement action as needed during the evaluation, he added.

Read full article
I'm already a subscriber

Freddie Dawson

Managing editor, news
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the ECigIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation